LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES
LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES
Depository Receipt · US52490G1022 · LEGN · A2P5AH (XNAS)
Overview
38,46 USD
5,07 % 1,85 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
12.06.2025 18:00

Current Prices from LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
LEGN
USD
12.06.2025 18:00
38,46 USD
36,59 USD
+5,10 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
5,07 % 25,42 % 21,00 % 3,40 % 7,30 % -13,10 % 6,08 %

Company Profile for LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES Depository Receipt

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.

Invested Funds

The following funds have invested in: LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
33,95
Percentage (%)
0,08 %

Company Data

Name LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES
Company Legend Biotech Corporation
Symbol LEGN
Website https://www.legendbiotech.com
Primary Exchange XNAS NASDAQ
WKN A2P5AH
ISIN US52490G1022
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Dr. Ying Huang Ph.D.
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 2,6 T
Address 2101 Cottontail Lane, 08873 Somerset
IPO Date 2020-06-05

Ticker Symbols

Name Symbol
Frankfurt 9LB.F
NASDAQ LEGN

More Shares

Investors who LEGEND BIOTECHCORP - AMERICAN DEPOSITARY SHARES hold also have the following shares in their portfolio:
LANDWIRT.R.BK 17/27MN MTN
LANDWIRT.R.BK 17/27MN MTN Bond
LOWE'S CO 17/47
LOWE'S CO 17/47 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025